Celldex plunges; drug stock indexes climb

Celldex Therapeutics shares plunge in early trading after the biotech group announces that Pfizer Inc. was pulling out of a pact to develop Celldex's cancer vaccine CDX-110.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.